Cargando…
Clinical Trials in Pancreatic Cancer: A Long Slog
Many investigators have turned their efforts toward improving the gemcitabine/nab‐paclitaxel combination by the addition of a third agent. This commentary highlights efforts to date, including the Clinical Trial Results by Ko et al.: A Randomized Double‐Blinded Phase II Trial of Gemcitabine and Nab‐...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AlphaMed Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5728038/ https://www.ncbi.nlm.nih.gov/pubmed/28982802 http://dx.doi.org/10.1634/theoncologist.2017-0453 |
_version_ | 1783285999724396544 |
---|---|
author | Enzler, Thomas Bates, Susan |
author_facet | Enzler, Thomas Bates, Susan |
author_sort | Enzler, Thomas |
collection | PubMed |
description | Many investigators have turned their efforts toward improving the gemcitabine/nab‐paclitaxel combination by the addition of a third agent. This commentary highlights efforts to date, including the Clinical Trial Results by Ko et al.: A Randomized Double‐Blinded Phase II Trial of Gemcitabine and Nab‐Paclitaxel Plus Apatorsen or Placebo in Patients with Metastati Pancreatic Cancer: The RAINIER Trial. |
format | Online Article Text |
id | pubmed-5728038 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | AlphaMed Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-57280382017-12-17 Clinical Trials in Pancreatic Cancer: A Long Slog Enzler, Thomas Bates, Susan Oncologist Commentaries Many investigators have turned their efforts toward improving the gemcitabine/nab‐paclitaxel combination by the addition of a third agent. This commentary highlights efforts to date, including the Clinical Trial Results by Ko et al.: A Randomized Double‐Blinded Phase II Trial of Gemcitabine and Nab‐Paclitaxel Plus Apatorsen or Placebo in Patients with Metastati Pancreatic Cancer: The RAINIER Trial. AlphaMed Press 2017-10-05 2017-12 /pmc/articles/PMC5728038/ /pubmed/28982802 http://dx.doi.org/10.1634/theoncologist.2017-0453 Text en © AlphaMed Press 2017 |
spellingShingle | Commentaries Enzler, Thomas Bates, Susan Clinical Trials in Pancreatic Cancer: A Long Slog |
title | Clinical Trials in Pancreatic Cancer: A Long Slog |
title_full | Clinical Trials in Pancreatic Cancer: A Long Slog |
title_fullStr | Clinical Trials in Pancreatic Cancer: A Long Slog |
title_full_unstemmed | Clinical Trials in Pancreatic Cancer: A Long Slog |
title_short | Clinical Trials in Pancreatic Cancer: A Long Slog |
title_sort | clinical trials in pancreatic cancer: a long slog |
topic | Commentaries |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5728038/ https://www.ncbi.nlm.nih.gov/pubmed/28982802 http://dx.doi.org/10.1634/theoncologist.2017-0453 |
work_keys_str_mv | AT enzlerthomas clinicaltrialsinpancreaticcanceralongslog AT batessusan clinicaltrialsinpancreaticcanceralongslog |